ABSA International
ABSA International

Resources with keywords: covid-19



New SARS-CoV-2 Variant of Concern Identified: Omicron (B.1.1.529) Variant
CDC / Health Alert Network

Due to the increased transmissibility of the Omicron variant and concerns about potential impacts on the healthcare system, the CDC is updating recommendations to enhance protection for healthcare personnel, patients, and visitors, and ensure adequate staffing in healthcare facilities.

Rapid Increase of Omicron Variant Infections in the United States: Management of Healthcare Personnel with SARS-CoV-2 Infection or Exposure
CDC / Health Alert Network

Due to the increased transmissibility of the Omicron variant and concerns about potential impacts on the healthcare system, the CDC is updating recommendations to enhance protection for healthcare personnel, patients, and visitors, and ensure adequate staffing in healthcare facilities.

Cumulative Mortality and Factors Associated With Outcomes of Mucormycosis After COVID-19 at a Multispecialty Tertiary Care Center in India (NEW 2/3, Website, Publication)
JAMA Ophthalmology
1 January 2022

Choksi T, et al.

An outbreak of COVID-19-associated rhino-orbitocerebral mucormycosis (CAM) has occurred in many parts of the world. Although the clinical profile and risk factors for CAM have been studied, cumulative mortality and its risk factors have not.

Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study (NEW 2/3, Website, Publication)
The Lancet: Infectious Diseases
1 January 2022

Antonelli M, et al.

This study aimed to identify risk factors for post-vaccination SARS-CoV-2 infection and describe the characteristics of post-vaccination illness.

Airborne Transmission of SARS-CoV-2 Delta Variant within Tightly Monitored Isolation Facility, New Zealand (Aotearoa)
CDC - Emerging Infectious Diseases
29 December 2021

Fox-Lewis A, Williamson F, Harrower J, Ren X, Sonder GJB, McNeill A, et al.

Predictors of SARS-CoV-2 infection following high-risk exposure (NEW 2/3, Website, Publication)
NIH
21 December 2021

Andrejko KL, et al.

Non-pharmaceutical interventions (NPIs) are recommended for COVID-19 prevention. However, the effectiveness of NPIs in preventing SARS-CoV-2 transmission remains poorly quantified.

keywords: covid-19, NPI, prevention
COVID-19: Scientific Updates (Website)
The Barcelona Institute for Global Health (ISGlobal)

Part 2 outlines what makes a good mask study and why so many fail.

keywords: covid-19
COMMENTARY: What can masks do? Part 2: What makes for a good mask study — and why most fail (Website)
CIDRAP
15 December 2021

Part 2 outlines what makes a good mask study and why so many fail.

keywords: covid-19, facemask, PPE
COMMENTARY: What can masks do? Part 1: The science behind COVID-19 protection (Website)
CIDRAP
14 October 2021

Part 1 of a two-part commentary explains the differences in cloth face coverings and surgical masks, the science of respiratory protection, and the hierarchy of disease controls.

keywords: covid-19, facemask, PPE
Lab Testing Capacity and Capability Data Dashboard (Website)
Association of Public Health Laboratories (APHL)

APHL has conducted a weekly survey of 99 state, local and territorial public health laboratories (PHLs) to collect the status of current and projected capability and capacity of laboratories to test for SARS-CoV-2, the virus that causes the Coronavirus Disease (COVID-19).

Go to Top